COMP <GO>

COR vs JNJ // ALTMAN Z-SCORE & DEBT/EQUITY

Cencora Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: COR 5 — JNJ 10

▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: JNJ

LAST: $330.84 (+0.09%) • MKT CAP: $63.07B

balance-sheet

5.27

LAST: $273.20 (-0.73%) • MKT CAP: $662.49B

balance-sheet

5.59

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COR VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	COR	JNJ	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	3.60%	67.90%	-64.30	JNJ	/gross-margins <GO>
Return on Invested Capital (ROIC)	26.80%	25.50%	+1.30	COR	/roic <GO>
EV/EBITDA & P/E Valuation	21.6x	18.5x	+3.10	JNJ	/valuation <GO>
Free Cash Flow Yield	5.08%	2.97%	+2.11	COR	/fcf-yield <GO>
Operating Margin	0.80%	34.70%	-33.90	JNJ	/operating-margins <GO>
Net Profit Margin	0.50%	28.50%	-28.00	JNJ	/net-margins <GO>
Revenue Growth (YoY)	9.30%	6.00%	+3.30	COR	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.69%	0.00%	+0.69	COR	/dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE	5.27	5.59	-0.32	JNJ	/balance-sheet <GO>
Piotroski F-Score Quality	6/9	8/9	-2.00	JNJ	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	6.50%	7.20%	-0.70	COR	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	54.1	60.4	-6.21	JNJ	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	0.88	1.08	-0.20	JNJ	/macro-sensitivity <GO>
Forward P/E Multiple	37.8x	23.0x	+14.80	JNJ	/forward-pe <GO>
Enterprise Scale & Market Cap	$63.07B	$662.49B	-$599.42B	JNJ	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	COR REV	JNJ REV	COR GROSS %	JNJ GROSS %	COR FCF	JNJ FCF
FY 2025	$321.33B	$94.19B	3.6%	67.9%	$3.21B	$19.70B
FY 2024	$293.96B	$88.82B	3.4%	69.1%	$3.00B	$19.84B
FY 2023	$262.17B	$85.16B	44.0%	44.0%	-$7.89B	$18.96B

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

COR // BETA 0.88

JNJ // BETA 1.08